Exact Sciences Corporation (EXAS) Reports Q1 Loss of 8c, Beats by a Penny
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
CFFI, ZGN, SSNC, More
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
CFFI, ZGN, SSNC, More
Join SI Premium – FREE
Exact Sciences Corporation (NASDAQ: EXAS) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.12 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Rollins falls 7% on third quarter earnings and revenue miss
- Hexcel falls on revenue miss and weak guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
